Risks of harm with cannabinoids, cannabis, and cannabis-based medicine for pain management relevant to patients receiving pain treatment

Protocol for an overview of systematic reviews

Ian Gilron, Fiona M. Blyth, Louisa Degenhardt, Marta Di Forti, Christopher Eccleston, Simon Haroutounian, Andrew Moore, Andrew S.C. Rice, Mark Wallace

Research output: Contribution to journalReview article

1 Citation (Scopus)

Abstract

Introduction:With the increasing availability of cannabis and cannabinoids and their potential utility for pain treatment, there is a growing need to evaluate the risk-benefit considerations of cannabinoids for the management of pain. As part of the IASP Cannabis and Cannabinoids Task Force, this protocol describes a planned overview of systematic reviews summarizing the risks of harm with cannabinoids that are relevant to patients receiving pain treatment.Methods:This overview will involve literature searches of several databases and a defined search strategy that will target systematic reviews or meta-analyses of cannabinoids where harms are the primary focus. Data extraction will include various features of the cannabinoid(s) and the harm(s) being studied as well as other methodological features of each included systematic review. Methodological quality of each included review will be assessed using AMSTAR-2 as well as compliance with the PRISMA harms checklist. Prospero registration pending.Discussion:The broad overview of reviews defined by this protocol is expected to synthesize available good quality evidence of harms that will help inform risk-benefit considerations about the use of cannabinoids for pain management.

Original languageEnglish
Article numbere742
Pages (from-to)1-3
Number of pages3
JournalPain Reports
Volume4
Issue number3
DOIs
Publication statusPublished - 1 May 2019

Keywords

  • Adverse effects
  • Adverse events
  • Cannabinoids
  • Cannabis
  • Clinical trials
  • Harms
  • Pain management

ASJC Scopus subject areas

  • Anesthesiology and Pain Medicine

Cite this

Risks of harm with cannabinoids, cannabis, and cannabis-based medicine for pain management relevant to patients receiving pain treatment : Protocol for an overview of systematic reviews. / Gilron, Ian; Blyth, Fiona M.; Degenhardt, Louisa; Di Forti, Marta; Eccleston, Christopher; Haroutounian, Simon; Moore, Andrew; Rice, Andrew S.C.; Wallace, Mark.

In: Pain Reports, Vol. 4, No. 3, e742, 01.05.2019, p. 1-3.

Research output: Contribution to journalReview article

Gilron, Ian ; Blyth, Fiona M. ; Degenhardt, Louisa ; Di Forti, Marta ; Eccleston, Christopher ; Haroutounian, Simon ; Moore, Andrew ; Rice, Andrew S.C. ; Wallace, Mark. / Risks of harm with cannabinoids, cannabis, and cannabis-based medicine for pain management relevant to patients receiving pain treatment : Protocol for an overview of systematic reviews. In: Pain Reports. 2019 ; Vol. 4, No. 3. pp. 1-3.
@article{1fc2326949044206acd011c1b14e5c71,
title = "Risks of harm with cannabinoids, cannabis, and cannabis-based medicine for pain management relevant to patients receiving pain treatment: Protocol for an overview of systematic reviews",
abstract = "Introduction:With the increasing availability of cannabis and cannabinoids and their potential utility for pain treatment, there is a growing need to evaluate the risk-benefit considerations of cannabinoids for the management of pain. As part of the IASP Cannabis and Cannabinoids Task Force, this protocol describes a planned overview of systematic reviews summarizing the risks of harm with cannabinoids that are relevant to patients receiving pain treatment.Methods:This overview will involve literature searches of several databases and a defined search strategy that will target systematic reviews or meta-analyses of cannabinoids where harms are the primary focus. Data extraction will include various features of the cannabinoid(s) and the harm(s) being studied as well as other methodological features of each included systematic review. Methodological quality of each included review will be assessed using AMSTAR-2 as well as compliance with the PRISMA harms checklist. Prospero registration pending.Discussion:The broad overview of reviews defined by this protocol is expected to synthesize available good quality evidence of harms that will help inform risk-benefit considerations about the use of cannabinoids for pain management.",
keywords = "Adverse effects, Adverse events, Cannabinoids, Cannabis, Clinical trials, Harms, Pain management",
author = "Ian Gilron and Blyth, {Fiona M.} and Louisa Degenhardt and {Di Forti}, Marta and Christopher Eccleston and Simon Haroutounian and Andrew Moore and Rice, {Andrew S.C.} and Mark Wallace",
year = "2019",
month = "5",
day = "1",
doi = "10.1097/PR9.0000000000000742",
language = "English",
volume = "4",
pages = "1--3",
journal = "Pain Reports",
issn = "2471-2531",
publisher = "Lippincott Williams & Wilkins",
number = "3",

}

TY - JOUR

T1 - Risks of harm with cannabinoids, cannabis, and cannabis-based medicine for pain management relevant to patients receiving pain treatment

T2 - Protocol for an overview of systematic reviews

AU - Gilron, Ian

AU - Blyth, Fiona M.

AU - Degenhardt, Louisa

AU - Di Forti, Marta

AU - Eccleston, Christopher

AU - Haroutounian, Simon

AU - Moore, Andrew

AU - Rice, Andrew S.C.

AU - Wallace, Mark

PY - 2019/5/1

Y1 - 2019/5/1

N2 - Introduction:With the increasing availability of cannabis and cannabinoids and their potential utility for pain treatment, there is a growing need to evaluate the risk-benefit considerations of cannabinoids for the management of pain. As part of the IASP Cannabis and Cannabinoids Task Force, this protocol describes a planned overview of systematic reviews summarizing the risks of harm with cannabinoids that are relevant to patients receiving pain treatment.Methods:This overview will involve literature searches of several databases and a defined search strategy that will target systematic reviews or meta-analyses of cannabinoids where harms are the primary focus. Data extraction will include various features of the cannabinoid(s) and the harm(s) being studied as well as other methodological features of each included systematic review. Methodological quality of each included review will be assessed using AMSTAR-2 as well as compliance with the PRISMA harms checklist. Prospero registration pending.Discussion:The broad overview of reviews defined by this protocol is expected to synthesize available good quality evidence of harms that will help inform risk-benefit considerations about the use of cannabinoids for pain management.

AB - Introduction:With the increasing availability of cannabis and cannabinoids and their potential utility for pain treatment, there is a growing need to evaluate the risk-benefit considerations of cannabinoids for the management of pain. As part of the IASP Cannabis and Cannabinoids Task Force, this protocol describes a planned overview of systematic reviews summarizing the risks of harm with cannabinoids that are relevant to patients receiving pain treatment.Methods:This overview will involve literature searches of several databases and a defined search strategy that will target systematic reviews or meta-analyses of cannabinoids where harms are the primary focus. Data extraction will include various features of the cannabinoid(s) and the harm(s) being studied as well as other methodological features of each included systematic review. Methodological quality of each included review will be assessed using AMSTAR-2 as well as compliance with the PRISMA harms checklist. Prospero registration pending.Discussion:The broad overview of reviews defined by this protocol is expected to synthesize available good quality evidence of harms that will help inform risk-benefit considerations about the use of cannabinoids for pain management.

KW - Adverse effects

KW - Adverse events

KW - Cannabinoids

KW - Cannabis

KW - Clinical trials

KW - Harms

KW - Pain management

UR - http://www.scopus.com/inward/record.url?scp=85071114197&partnerID=8YFLogxK

U2 - 10.1097/PR9.0000000000000742

DO - 10.1097/PR9.0000000000000742

M3 - Review article

VL - 4

SP - 1

EP - 3

JO - Pain Reports

JF - Pain Reports

SN - 2471-2531

IS - 3

M1 - e742

ER -